ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 113.40
-0.10 (-0.09%)
May 29, 2026, 5:36 PM CET
ABIVAX Société Anonyme Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | 4.92 | 4.57 | 12.43 | 4.57 | 4.51 | 4.2 |
| 4.92 | 4.57 | 12.43 | 4.57 | 4.51 | 4.2 | |
Revenue Growth (YoY) | -59.82% | -63.22% | 171.67% | 1.53% | 7.18% | 29921.43% |
Gross Profit | 4.92 | 4.57 | 12.43 | 4.57 | 4.51 | 4.2 |
Selling, General & Admin | 72 | 72.86 | 38.9 | 28.82 | 7.49 | 5.58 |
Research & Development | 188 | 177.76 | 146.53 | 103.18 | 48.3 | 47.78 |
Other Operating Expenses | - | - | -0.02 | -0.05 | -0.08 | -0.04 |
Operating Expenses | 260 | 250.63 | 185.41 | 131.95 | 55.71 | 53.33 |
Operating Income | -255.08 | -246.06 | -172.98 | -127.38 | -51.2 | -49.12 |
Interest Expense | -26.49 | -28.48 | -12.43 | -13.83 | -6.94 | -3.56 |
Interest & Investment Income | 5.39 | 5.6 | 8.25 | 2.42 | - | - |
Currency Exchange Gain (Loss) | 5.81 | -1.56 | 2.72 | -5.57 | - | - |
Other Non Operating Income (Expenses) | -64.8 | -64.49 | -1.8 | -6.58 | 9.59 | 2.51 |
EBT Excluding Unusual Items | -335.18 | -334.98 | -176.24 | -150.94 | -48.55 | -50.17 |
Impairment of Goodwill | - | - | - | - | -13.63 | - |
Other Unusual Items | 9.06 | 4.73 | - | 3.2 | 1.45 | 7.72 |
Pretax Income | -326.12 | -330.25 | -176.24 | -147.74 | -60.74 | -42.45 |
Income Tax Expense | 6.08 | 5.85 | - | - | - | - |
Net Income | -332.2 | -336.1 | -176.24 | -147.74 | -60.74 | -42.45 |
Net Income to Common | -332.2 | -336.1 | -176.24 | -147.74 | -60.74 | -42.45 |
Shares Outstanding (Basic) | 73 | 70 | 63 | 43 | 19 | 15 |
Shares Outstanding (Diluted) | 73 | 70 | 63 | 43 | 19 | 15 |
Shares Change (YoY) | 16.25% | 10.28% | 46.39% | 125.57% | 23.53% | 7.84% |
EPS (Basic) | -4.52 | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 |
EPS (Diluted) | -4.52 | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 |
Free Cash Flow | -178.52 | -161.27 | -154.71 | -97.4 | -54.22 | -45.1 |
Free Cash Flow Per Share | -2.43 | -2.32 | -2.45 | -2.26 | -2.84 | -2.92 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -5184.63% | -5384.14% | -1392.11% | -2784.78% | -1136.60% | -1168.74% |
Profit Margin | -6752.03% | -7354.53% | -1418.33% | -3230.00% | -1348.28% | -1010.04% |
Free Cash Flow Margin | -3628.50% | -3528.91% | -1245.07% | -2129.32% | -1203.64% | -1072.92% |
EBITDA | -254 | -244.98 | -171.88 | -126.67 | -50.72 | -49.07 |
D&A For EBITDA | 1.08 | 1.07 | 1.1 | 0.71 | 0.49 | 0.05 |
EBIT | -255.08 | -246.06 | -172.98 | -127.38 | -51.2 | -49.12 |
Revenue as Reported | 4.92 | 4.57 | 12.45 | 4.62 | 4.58 | 11.96 |